文献速递中枢神经肿瘤放疗放疗物理与技术

极高危髓母细胞瘤图像引导颅脊髓照射的临床前建模

Preclinical Modeling of Image-Guided Craniospinal Irradiation for Very-High-Risk Medulloblastoma.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-10-23

研究利用配备电动可变准直器的小动物辐射研究平台,对颅内原位种植极高危Group 3或Sonic Hedgehog亚型髓母细胞瘤患者来源异种移植瘤的小鼠实施图像引导颅脊髓照射,以2 Gy/次分次照射至累积36 Gy。颅脊髓照射改善了小鼠生存,常规分次≥20 Gy时各模型均显示显著放射反应性,且耐受良好,急性白细胞减少在治疗结束后不久恢复。

要点

  • 建立了可重复的小鼠图像引导颅脊髓照射临床前方案,累积剂量36 Gy、2 Gy/次。
  • 颅脊髓照射改善极高危Group 3或Sonic Hedgehog亚型髓母细胞瘤小鼠生存。
  • 各模型放射反应性提示常规分次颅脊髓照射≥20 Gy时具有显著放射反应性。

核心结论

  • 临床前颅脊髓照射方案有效且耐受良好,可整合进髓母细胞瘤及其他中枢神经系统播散性肿瘤的临床前研究流程。

研究设计与样本

  • 使用配备电动可变准直器的小动物辐射研究平台进行图像引导颅脊髓照射。
  • 小鼠脑皮质内植入极高危Group 3或Sonic Hedgehog亚型髓母细胞瘤患者来源原位异种移植瘤。
  • 照射方案为2 Gy/次分次颅脊髓照射,累积36 Gy。
  • 评估肿瘤负荷和总生存的放射剂量效应,用生物发光法确定治疗失败模式并经组织学确认。
  • 通过体重测量和血液检查评估急性毒性。

主要发现

  • 颅脊髓照射改善了携带极高危Group 3或Sonic Hedgehog亚型髓母细胞瘤患者来源原位异种移植瘤小鼠的生存。
  • 各模型放射剂量反应提示对常规分次颅脊髓照射≥20 Gy具有显著放射反应性。
  • 小鼠体重无显著变化,出现急性白细胞减少但在治疗结束后不久恢复。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Craniospinal irradiation (CSI) is a crucial component of treatment for medulloblastoma (MB), a brain tumor clinically stratified into prognostically distinct molecular subgroups. Preclinical models of clinically relevant CSI offer the potential to study radiation dose and volume effects in these subgroups and to identify subgroup-specific combination adjuvant therapies, particularly for very-high-risk MB in which treatments are often unsuccessful. METHODS AND MATERIALS: The commercially available Small Animal Radiation Research Platform equipped with a motorized variable collimator was used for image-guided CSI. Mice were implanted in brain cortices with patient-derived orthotopic xenografts (PDOXs) of very-high-risk Group 3 (G3) or Sonic Hedgehog (SHH) MB and were treated with fully fractionated CSI at 2 Gy/fraction for a cumulative 36 Gy. Radiation therapy dose response effects on tumor burden and overall survival were assessed. The pattern of treatment failure was determined using bioluminescence and then confirmed histologically. Acute toxicity was appraised by body weight measurements and blood work. RESULTS: We established an accurate and efficient preclinical protocol to administer CSI reproducibly to mice harboring MB. CSI improved the survival of mice bearing very-high-risk G3 or SHH MB PDOXs. However, radiation therapy dose responses across models suggested significant radio-responsiveness to conventionally fractionated CSI ≥20 Gy. CSI was well tolerated; mice had no significant changes in body weight, and acute leukopenia developed but resolved soon after therapy completion. CONCLUSIONS: Our protocol for preclinical CSI delivery was effective and well tolerated, and it can be readily integrated into preclinical pipelines for MB and other central nervous system-seeding tumors.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Smith SMC, Bianski BM, Orr BA, et al. Preclinical Modeling of Image-Guided Craniospinal Irradiation for Very-High-Risk Medulloblastoma. Int J Radiat Oncol Biol Phys. 2018. PMID: 30366006. doi:10.1016/j.ijrobp.2018.10.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。